Practice Administration

Oncology Practice Landscape in 2018: ASCO Survey Shows Interactions with Payers Top Concern

Eileen Koutnik-Fotopoulos

October 2018, Vol 8, No 10 - Practice Management

Oncology practices are challenged by day-to-day operational functions, which are often related to payment, reimbursement, and competition, according to the new survey titled “The State of Oncology Practice in America” from the American Society of Clinical Oncology (ASCO) on the oncology practice landscape in the United States. [ Read More ]

FDA Commissioner Outlines New Plan to Increase Biosimilars by “Balancing Innovation and Competition”

Eileen Koutnik-Fotopoulos

October 2018, Vol 8, No 10 - Health Policy

FDA Commissioner Scott Gottlieb, MD, has been outspoken about the critical need to reign in drug prices. Biosimilars are crucial for improving patient access to biologic drugs at an affordable cost. Biologics are now key in the treatment of cancer and autoimmune conditions. But cost remains an obstacle to access to drug therapy. [ Read More ]

Top 4 Trends That Are Changing Oncology Practices

Gail Thompson

August 2018, Vol 8, No 8 - Practice Management

What are the most note­worthy trends that can affect an oncology practice’s strategic planning, budgeting, and bottom line? The Association of Community Cancer Centers (ACCC) partnered with the Advisory Board Company to identify some of those trends in the 2017 Trending Now in Cancer Care Survey. The survey results were presented at the 2018 ACCC Annual Meeting & Cancer Center Business Summit. [ Read More ]

Strategic Planning by Oncology Practices Can Provide a Roadmap to a Thriving Future

Elaine Estes

July 2018, Vol 8, No 7 - Practice Administration, Strategic Planning

Strategic planning for oncology practices is more important today than ever before, with the oncology landscape rapidly evolving, driven by complex issues not encountered previously. For example, the emergence of value-based care has added new layers of complexity to cancer care, because clinical changes associated with team-based care and documentation and data-­tracking requirements are significant. Practices today are also tasked with finding ways to expand patient access to ancillary support services that improve satisfaction and outcomes, while also keeping costs down. [ Read More ]

FDA Implements New Steps to Encourage Generic Drug Competition, Expand Patients’ Access to Inexpensive Medicines

Eileen Koutnik-Fotopoulos

April 2018, Vol 8, No 4 - Health Policy

In a January 3, 2018, statement from FDA Commissioner Scott Gottlieb, MD, the FDA announced new steps to promote generic drug competition as a way to expand potential access to inexpensive medicines, which would be especially helpful for patients with cancer. These new steps are a part of the FDA’s ongoing implementation of the Drug Competition Action Plan. [ Read More ]